ATLAS ACS 2-TIMI 51

AHA 2011 — A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects with Acute Coronary Syndrome


< Back to Listings